FDPS
Farnesyl pyrophosphate synthase
As of the edition of 20 October 2026, FDPS (farnesyl pyrophosphate synthase, UniProt P14324) has 7 drugs tested at it and 22 companies on the list, 0 on route A and 12 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- P14324
- How well studied
- Drug target: an approved drug acts on it
- Where it sits in the cell
- Inside the cell
- Solved structures
- 92
- Disease areas
- Bones, joints and muscles; Nutrition and metabolism; Cancer; Skin and connective tissue; Urinary and reproductive; Immune system; Blood and lymph; Injuries
- Registered trials of its drugs
- 523
Drugs at this target
| Status | Count |
|---|---|
| Marketed | 7 |
| Total | 7 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| Zoledronic acid anhydrous | Marketed | Phase 4 | none listed |
| Alendronic acid | Marketed | Phase 4 | none listed |
| Ibandronic acid | Marketed | Phase 4 | none listed |
| Risedronic acid | Marketed | Phase 4 | none listed |
| Pamidronic acid | Marketed | Phase 4 | none listed |
| Minodronic acid | Marketed | Phase 4 | none listed |
| Incadronic acid | Marketed | No phase stated | none listed |
7 of 7 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Route B | 12 |
| Engaged | 3 |
| Undetermined | 7 |
| Total on the list | 22 |
| Company | Route |
|---|---|
| Novartis | Route B |
| Merck & Co. | Route B |
| Pfizer | Route B |
The other 19 companies at FDPS
In the product22 companies in all; 19 are not named here, and no score is.
See the 22 companies at FDPS, ranked, with the facts behind eachRequest access. Nothing is shown until you do.